SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 182 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.3%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $3,654 | +2.0% | 97,031 | +33.3% | 0.00% | 0.0% |
| Q1 2024 | $3,582 | -36.4% | 72,779 | -52.8% | 0.00% | -50.0% |
| Q4 2023 | $5,631 | +148.6% | 154,273 | +57.6% | 0.00% | +100.0% |
| Q3 2023 | $2,265 | -29.0% | 97,916 | -19.6% | 0.00% | -50.0% |
| Q2 2023 | $3,192 | -81.1% | 121,760 | -81.5% | 0.00% | -75.0% |
| Q1 2023 | $16,933 | -33.3% | 657,865 | -32.6% | 0.01% | -27.3% |
| Q4 2022 | $25,381 | -99.4% | 975,812 | +540.4% | 0.01% | +120.0% |
| Q3 2022 | $4,348,000 | +1254.5% | 152,373 | +1068.9% | 0.01% | – |
| Q2 2022 | $321,000 | -78.9% | 13,036 | -51.6% | 0.00% | -100.0% |
| Q1 2022 | $1,520,000 | – | 26,932 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 7,281,307 | $347,100,000 | 32.35% |
| BVF INC/IL | 2,053,991 | $97,914,000 | 5.33% |
| Samsara BioCapital, LLC | 398,017 | $18,973,000 | 5.29% |
| Orbimed Advisors | 7,406,307 | $353,059,000 | 4.44% |
| Consonance Capital Management LP | 602,732 | $28,732,000 | 3.50% |
| Boxer Capital, LLC | 2,075,905 | $98,958,000 | 3.42% |
| Perceptive Advisors | 3,481,148 | $165,946,000 | 2.42% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,234,262 | $58,837,000 | 1.43% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 974,915 | $46,474,000 | 0.95% |
| HighVista Strategies LLC | 11,477 | $547,000 | 0.40% |